| abstract |
The present invention relates to the method for the treatment of cancer in a subject comprising administering to the subject in need thereof, a therapeutically effective amount of a rho GTPase inhibitor selected from a compound of formula (I) or a compound of formula (II), wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined in the specification, in all their stereoisomeric or tautomeric forms, and mixtures thereof in all ratios and their pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising a rho GTPase inhibitor selected from one or more compounds of formula (I) or compounds of formula (II) for use in the treatment of cancer. |